|
Re: New video quietly released
|
8
|
Resverlogix Corp.
|
Jan 29, 2022 01:15PM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
6
|
Zenith Epigenetics
|
Feb 07, 2022 12:27PM
|
|
Re: CBC Radio News Interview with Dr. Sweeney
|
10
|
Resverlogix Corp.
|
Feb 07, 2022 01:10PM
|
|
Re: The costs of Long Covid
|
6
|
Resverlogix Corp.
|
Feb 08, 2022 01:51PM
|
|
Corporate Year ends
|
3
|
Resverlogix Corp.
|
Feb 10, 2022 07:01PM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
3
|
Zenith Epigenetics
|
Feb 15, 2022 11:37AM
|
|
Re: Resverlogix Expands Phase 2b Clinical Trial for COVID-19
|
10
|
Resverlogix Corp.
|
Feb 17, 2022 12:31PM
|
|
Re: Debenture questions.
|
3
|
Resverlogix Corp.
|
Feb 17, 2022 12:57PM
|
|
Nature Briefing article
|
5
|
Resverlogix Corp.
|
Feb 18, 2022 10:16AM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
4
|
Zenith Epigenetics
|
Feb 19, 2022 01:23PM
|
|
Re: Calgary-developed COVID-19 drug begins trials in local hospitals and Brazil.
|
7
|
Resverlogix Corp.
|
Feb 20, 2022 12:06PM
|
|
Re: Zenith Epigenetics is proud to announce the appointment Dr. Brad Thompson, PhD to our Board of Directors!
|
3
|
Zenith Epigenetics
|
Feb 20, 2022 12:36PM
|
|
Re: Calgary-developed COVID-19 drug begins trials in local hospitals and Brazil.
|
2
|
Resverlogix Corp.
|
Feb 20, 2022 06:26PM
|
|
Re: https://themarkether...
|
6
|
Resverlogix Corp.
|
Feb 22, 2022 08:33PM
|
|
OTC Trading questions
|
1
|
Zenith Epigenetics
|
Mar 01, 2022 01:02PM
|
|
Re: https://themarkether...
|
10
|
Resverlogix Corp.
|
Mar 01, 2022 08:17PM
|
|
Re: OTC Trading questions
|
1
|
Zenith Epigenetics
|
Mar 01, 2022 08:18PM
|
|
Re: By the time….
|
3
|
Resverlogix Corp.
|
Mar 03, 2022 11:50AM
|
|
Re: OTC Trading questions
|
2
|
Zenith Epigenetics
|
Mar 03, 2022 12:04PM
|
|
Re: https://themarkether...
|
8
|
Resverlogix Corp.
|
Mar 04, 2022 11:53AM
|
